Atypical B cells (CD21-CD27-IgD-) correlate with lack of response to checkpoint inhibitor therapy in NSCLC
Open Access
- 10 November 2023
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 196, 113428
Abstract
No abstract availableKeywords
Funding Information
- Erasmus Medisch Centrum
This publication has 32 references indexed in Scilit:
- Presence of B Cells in Tertiary Lymphoid Structures Is Associated with a Protective Immunity in Patients with Lung CancerAmerican Journal of Respiratory and Critical Care Medicine, 2014
- Peripheral CD27−CD21− B-cells represent an exhausted lymphocyte population in hepatitis C cirrhosisClinical Immunology, 2014
- Oncology Meets Immunology: The Cancer-Immunity CycleImmunity, 2013
- SLE Peripheral Blood B Cell, T Cell and Myeloid Cell Transcriptomes Display Unique Profiles and Each Subset Contributes to the Interferon SignaturePLOS ONE, 2013
- Decoupling activation and exhaustion of B cells in spontaneous controllers of HIV infectionAIDS, 2013
- Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in miceBlood, 2012
- B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapyBlood, 2010
- Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patientsArthritis Research & Therapy, 2010
- Homeostatic proliferation of B cellsSeminars in Immunology, 2005
- Decreased Survival of B Cells of HIV-viremic Patients Mediated by Altered Expression of Receptors of the TNF SuperfamilyJournal of Experimental Medicine, 2004